Response rates for CBT for anxiety disorders: Need for standardized criteria
- PMID: 26319194
- DOI: 10.1016/j.cpr.2015.08.004
Response rates for CBT for anxiety disorders: Need for standardized criteria
Abstract
Full appreciation of the effectiveness of cognitive behavioral therapy (CBT) requires both effect size data and individual rates of positive response. Response rates are particularly helpful for clinicians when choosing among treatment options. However, systematic reviews on cross-study response rates have not been conducted, possibly due to the absence of a standardized metric for calculating response rates. We conducted a systematic review of the treatment outcome literature to determine overall response rates to CBT for anxiety disorders and whether current methods of defining treatment response influence overall response rates. Our database search (2000-2014) resulted in 87 studies that reported response rates and included at least one CBT condition. Results showed that overall treatment response rates across anxiety disorders averaged 49.5% at post-treatment and 53.6% at follow-up. Response rates varied significantly as a function of the properties used to define them. Measures that incorporated more than one criterion, the combination of a reliable change index with a clinical cutoff (a clinically significant change), and intent-to-treat samples yielded lower response rates at post-treatment. Blinded independent assessors yielded higher response rates than unblinded assessors. Based on previous empirical and theoretical work, we recommend that future studies use a clinically significant change index, in an intent-to-treat analysis (using a mixed-model approach), reflecting multiple modalities, and assessed by independent blinded assessors. Our results indicate that such measures are likely to reduce response rates, but may result in a less biased and more accurate representation of improvement and achievement of normative functioning.
Keywords: Anxiety disorders; CBT; Effectiveness; Response rates.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Similar articles
-
Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults.Cochrane Database Syst Rev. 2016 Mar 12;3(3):CD011565. doi: 10.1002/14651858.CD011565.pub2. Cochrane Database Syst Rev. 2016. PMID: 26968204 Free PMC article.
-
Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults.Cochrane Database Syst Rev. 2015 Mar 5;(3):CD011565. doi: 10.1002/14651858.CD011565. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2016 Mar 12;3:CD011565. doi: 10.1002/14651858.CD011565.pub2. PMID: 25742186 Updated.
-
Psychological therapies for temporomandibular disorders (TMDs).Cochrane Database Syst Rev. 2022 Aug 11;8(8):CD013515. doi: 10.1002/14651858.CD013515.pub2. Cochrane Database Syst Rev. 2022. PMID: 35951347 Free PMC article.
-
Cognitive behavioural therapy and third-wave approaches for anxiety and related disorders in older people.Cochrane Database Syst Rev. 2024 Jul 8;7(7):CD007674. doi: 10.1002/14651858.CD007674.pub3. Cochrane Database Syst Rev. 2024. PMID: 38973756 Free PMC article.
-
Cognitive behavioural therapy (CBT) with and without exercise to reduce fear of falling in older people living in the community.Cochrane Database Syst Rev. 2023 Nov 15;11(11):CD014666. doi: 10.1002/14651858.CD014666.pub2. Cochrane Database Syst Rev. 2023. PMID: 37965937 Free PMC article.
Cited by
-
Simulating the computational mechanisms of cognitive and behavioral psychotherapeutic interventions: insights from active inference.Sci Rep. 2021 May 12;11(1):10128. doi: 10.1038/s41598-021-89047-0. Sci Rep. 2021. PMID: 33980875 Free PMC article.
-
Metabolomic Biomarkers in Anxiety Disorders.Int J Mol Sci. 2020 Jul 6;21(13):4784. doi: 10.3390/ijms21134784. Int J Mol Sci. 2020. PMID: 32640734 Free PMC article. Review.
-
Neural circuitry involved in conditioned inhibition via safety signal learning is sensitive to trauma exposure.Neurobiol Stress. 2022 Oct 17;21:100497. doi: 10.1016/j.ynstr.2022.100497. eCollection 2022 Nov. Neurobiol Stress. 2022. PMID: 36532365 Free PMC article.
-
Developing Transdiagnostic Internalizing Disorder Prognostic Indices for Outpatient Cognitive Behavioral Therapy.Behav Ther. 2023 May;54(3):461-475. doi: 10.1016/j.beth.2022.11.004. Epub 2022 Dec 7. Behav Ther. 2023. PMID: 37088504 Free PMC article.
-
The enhancing effects of testosterone in exposure treatment for social anxiety disorder: a randomized proof-of-concept trial.Transl Psychiatry. 2021 Aug 20;11(1):432. doi: 10.1038/s41398-021-01556-8. Transl Psychiatry. 2021. PMID: 34417443 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical